Compound Detail
CHEMBL1096
AMLEXANOX 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1096 |
| Name | AMLEXANOX |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | SGRYPYWGNKJSDL-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
6
Targets
10
Activities
3
Assay Types
0
PK Parameters
20
Publications
10
Known Names
2
Indications
1
Mechanisms
Molecular Properties
298.3
MW (Da)
2.75
ALogP
5
HBA
2
HBD
106.4
PSA (Ų)
0.70
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1996 |
| Availability | Discontinued |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Phosphodiesterase 4 inhibitor | INHIBITOR | Phosphodiesterase 4 | ✓ | ✓ |
Indications
Lung Diseases, Obstructive Stomatitis
ATC Classification
A01AD07
amlexanox
Level 1: ALIMENTARY TRACT AND METABOLISM
Level 2: STOMATOLOGICAL PREPARATIONS
R03DX01
amlexanox
Level 1: RESPIRATORY SYSTEM
Level 2: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Activity Summary
IC50 8 meas. best 6.07
EC50 1 meas. best 5.4
Kd 1 meas. best 4.7
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Serine/threonine-protein kinase TBK1 CHEMBL5408 | IC50 | 6.07 | 6.05 | 850.0 | 3 |
| ATP-binding cassette sub-family C member 4 CHEMBL1743128 | IC50 | 5.66 | 5.66 | 2200.0 | 1 |
| G-protein coupled receptor 35 CHEMBL1293267 | EC50 | 5.4 | 5.4 | 4000.0 | 1 |
| Inhibitor of nuclear factor kappa-B kinase subunit epsilon CHEMBL3529 | IC50 | 5.29 | 5.29 | 5100.0 | 2 |
| G protein-coupled receptor kinase 5 CHEMBL3721302 | IC50 | 5.05 | 5.05 | 8860.0 | 1 |
| Transthyretin CHEMBL3194 | Kd | 4.7 | 4.7 | 20000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 16472241 | 10.2174/1570163043334794 | Hepatotoxicity | 18 |
| 34547896 | 10.1021/acs.jmedchem.1c00823 | Transthyretin | 6 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 4 |
| 30270002 | 10.1016/j.bmc.2018.09.020 | Inhibitor of nuclear factor kappa-B kinase subunit epsilon | 3 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 3 |
| 30270002 | 10.1016/j.bmc.2018.09.020 | Mus musculus | 3 |
| 3989816 | 10.1021/jm50001a005 | Rattus norvegicus | 3 |
| 30270002 | 10.1016/j.bmc.2018.09.020 | Serine/threonine-protein kinase TBK1 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Mu-type opioid receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Androgen receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2A | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 1A | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 2 |
| 27976894 | 10.1021/acs.jmedchem.6b01431 | G-protein coupled receptor 35 | 1 |
| 30270002 | 10.1016/j.bmc.2018.09.020 | No relevant target | 1 |
| 36055000 | 10.1016/j.ejmech.2022.114668 | G protein-coupled receptor kinase 5 | 1 |
Data from ChEMBL 36 via Core Engine